Accession Number:

ADA470954

Title:

Magnetic Resonance Spectroscopy (MRS) of Prostatic Fluids for Early Detection of Prostate Cancer

Descriptive Note:

Final addendum rept. 14 Oct 2006-31 Mar 2007

Corporate Author:

COLORADO UNIV HEALTH SCIENCES CENTER DENVER

Report Date:

2007-04-01

Pagination or Media Count:

33.0

Abstract:

In this study, the metabolic profiles of expressed prostatic secretions EPS from 52 men with prostate cancer PCa and from 26 healthy controls were analyzed using quantitative proton nuclear magnetic resonance spectroscopy 1H-NMRS. The metabolites quantified included citrate, spermine, myo-inositol, lactate, alanine, phosphocholine, glutamine, acetate, and hydroxybutyrate. Logistic regression LR was used to model the risk of PCa based on metabolite concentrations while adjusting for age. The LR models indicated that the absolute concentrations of citrate, myo-inositol, and spermine were highly predictive of PCa and inversely related to the risk of PCa. The areas under the receiver operating characteristic curves AUROC for citrate, myo-inositol and spermine were 0.89, 0.87, and 0.79, respectively. At 90 sensitivity, these metabolites had specificities of 74, 51 and 34, respectively. The LR analysis indicated that absolute levels of these three metabolites were independent of age. The results indicate that citrate, myo-inositol and spermine are potentially important markers of PCa in human EPS. Further, the absolute concentration of these metabolites in EPS appears to be independent of age, increasing the potential utility of these markers due to elimination of age as a confounding variable.

Subject Categories:

  • Biochemistry
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE